5 Oversold Value Stocks To Buy

3. First Wave BioPharma, Inc. (NASDAQ:FWBI)

Latest 14 Day RSI Score: 19.97

First Wave BioPharma, Inc. (NASDAQ:FWBI) is a biotechnology firm that develops treatments for digestive system disorders and diseases. In a letter to shareholders released in July, the firm’s CEO shared that its trials of a pancreas drug are proceeding smoothly and if the drug is successful then it will play in a $2.2 billion market.

During March 2023, only one hedge fund out of the 943 funds part of Insider Monkey’s database had bought First Wave BioPharma, Inc. (NASDAQ:FWBI)’s shares. This lone investor is Steven Boyd’s Armistice Capital which owns $240,814 worth of company shares.

Follow Entero Therapeutics Inc. (NASDAQ:ENTO)